Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Ocular Inflammation Age: Adult Condition: Steroid-responsive ocular inflammations with risk of superficial bacterial infections |
Dose: Drops – 1 or 2 drops Frequency: every 4 to 6 hours Note: Instill into the conjunctival sac of the affected eye(s). Decrease frequency of administration as signs and symptoms improve. |
|
Indication: Ocular Inflammation Age: Adult Condition: Steroid-responsive ocular inflammations with risk of superficial bacterial infections (First 24-48 hours) |
Dose: Drops – 1 or 2 drops Frequency: every 1 to 2 hours Duration: first 24 to 48 hours Note: Instill into the conjunctival sac of the affected eye(s). Decrease frequency of administration as signs and symptoms improve. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: Safety and efficacy not been established. Note: Safety and efficacy not been established. |
Administration
- Wash hands first
- Don't touch tip
Side Effect
- Prolonged use may increase IOP, which may be associated with possible development of glaucoma and infrequent optic nerve damage
- posterior sub-capsular cataract formation and perforation of the globe where there is thinning of the cornea or sclera
- The most frequent adverse reactions to topical tobramycin are hypersensitivity and localized ocular toxicity including lid itching and swelling and conjunctival erythema
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Other aminoglycosides, Cefaloridine, Viomycin, Polymyxin B, Colistin, Cisplatin, Vancomycin
|
Enhanced neurotoxic and nephrotoxic effects
|
|
Ethacrynic acid, Furosemide
|
Enhanced toxicity
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Viral infections
|
Can mask or worsen infection
|
|
Mycobacterial infections
|
Risk of infection spread
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at room temperature & protect from light. Do not touch dropper tip to any surface. It is desirable that the contents should not be used four weeks after first opening of the bottle. Protect from freezing.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.